semaglutide vs tirzepatide difference vs. for Weight Loss Tirzepatide vs Semaglutide Compared |

Blood Sugar Regulation: GLP-1 receptor agonists like semaglutide stimulate the release of insulin from the pancreas in response to elevated blood sugar levels

Wegovy received FDA approval for long-term weight loss in December 2021, leading to high demand but also making it difficult to obtain due to its relatively high price and lack of insurance coverage

dollars that Medicaid has spent on the most common GLP-1s (Ozempic, Mounjaro, Rybelsus, Saxenda, Wegovy, and Zepbound)

This includes growth hormone, most antibody fragments, and larger peptide hormones

Its multi-targeted approach makes it especially helpful for individuals experiencing hair changes while on GLP-1 medications